Drug Database
L03AA02 filgrastim
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Accofil 12 MU/0.2 mL solution for injection or infusion in pre-filled syringe
- POM Accofil 70 MU/0.73 ml solution for injection or infusion in pre-filled syringe
- POM Neupogen 30 MU (0.3 mg/ml) solution for injection
- POM Neupogen Singleject 30 MU (0.6 mg/ml)
- POM Neupogen Singleject 48 MU (0.96 mg/ml)
- POM Nivestim 12 MU/ 0.2 ml solution for injection/infusion
- POM Nivestim 30 MU/0.5 ml solution for injection/infusion
- POM Nivestim 48 MU/0.5 ml solution for injection/infusion
- POM Zarzio 30MU/0.5ml solution for injection or infusion in pre-filled syringe (GB)
- POM Zarzio 48MU/0.5ml solution for injection or infusion in pre-filled syringe
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).